Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Fatal infection due to extended-spectrum beta-lactamase-producing Escherichia coli: implications for antibiotic choice for spontaneous bacterial peritonitis.

× No keyword cloud information.

11 in total

1. BetalasEN: microdilution panel for identifying beta-lactamases present in isolates of Enterobacteriaceae.

Authors: Christine C Sanders; Anton F Ehrhardt; Ellen Smith Moland; Kenneth S Thomson; Barbara Zimmer; Darcie E Roe
Journal: J Clin Microbiol Date: 2002-01 Impact factor: 5.948

2. Occurrence of newer beta-lactamases in Klebsiella pneumoniae isolates from 24 U.S. hospitals.

Authors: Ellen Smith Moland; Jennifer A Black; Jason Ourada; Mark D Reisbig; Nancy D Hanson; Kenneth S Thomson
Journal: Antimicrob Agents Chemother Date: 2002-12 Impact factor: 5.191

3. Epidemiology and clinical features of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in nonhospitalized patients.

Authors: Jesús Rodríguez-Baño; Maria Dolores Navarro; Luisa Romero; Luis Martínez-Martínez; Miguel A Muniain; Evelio J Perea; Ramón Pérez-Cano; Alvaro Pascual
Journal: J Clin Microbiol Date: 2004-03 Impact factor: 5.948

4. Emergence of community-acquired extended-spectrum beta-lactamase Escherichia coli (ESBLEC) in Honolulu: a case series of three individuals with community-acquired ESBLEC bacteriuria.

Authors: Reid R Hoshide; Heath Chung; Jinichi Tokeshi
Journal: Hawaii Med J Date: 2011-09

5. Clinical correlation of the CLSI susceptibility breakpoint for piperacillin- tazobactam against extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella species.

Authors: Patrick J Gavin; Mira T Suseno; Richard B Thomson; J Michael Gaydos; Carl L Pierson; Diane C Halstead; Jaber Aslanzadeh; Stephen Brecher; Coleman Rotstein; Stephen E Brossette; Lance R Peterson
Journal: Antimicrob Agents Chemother Date: 2006-06 Impact factor: 5.191

6. Inoculum effect on the efficacies of amoxicillin-clavulanate, piperacillin-tazobactam, and imipenem against extended-spectrum β-lactamase (ESBL)-producing and non-ESBL-producing Escherichia coli in an experimental murine sepsis model.

Authors: F Docobo-Pérez; L López-Cerero; R López-Rojas; P Egea; J Domínguez-Herrera; J Rodríguez-Baño; A Pascual; J Pachón
Journal: Antimicrob Agents Chemother Date: 2013-02-25 Impact factor: 5.191

7. Extended-spectrum β-lactamase (ESBL) in Omani Children: Study of prevalence, risk factors and clinical outcomes at Sultan Qaboos University Hospital, Sultanate of Oman.

Authors: Zakariya Al Muharrmi; Akbar M Rafay; Abdullah Balkhair; Salem Al-Tamemi; Ali Al Mawali; Hilal Al Sadiri
Journal: Sultan Qaboos Univ Med J Date: 2008-07

Review 8. Extended-spectrum beta-lactamases: a clinical update.

Authors: David L Paterson; Robert A Bonomo
Journal: Clin Microbiol Rev Date: 2005-10 Impact factor: 26.132

9. Cefepime, piperacillin-tazobactam, and the inoculum effect in tests with extended-spectrum beta-lactamase-producing Enterobacteriaceae.

Authors: K S Thomson; E S Moland
Journal: Antimicrob Agents Chemother Date: 2001-12 Impact factor: 5.191

10. Clinical outcome of bacteremic spontaneous bacterial peritonitis due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae.

Authors: Cheol-In Kang; Sung-Han Kim; Wan Beom Park; Ki Deok Lee; Hong Bin Kim; Myoung-Don Oh; Eui-Chong Kim; Hyo-Suk Lee; Kang Won Choe
Journal: Korean J Intern Med Date: 2004-09 Impact factor: 2.884